Roemmers opens $65 million pharma plant in Argentina

11 January 2001

Roemmers, Argentina's largest pharmaceutical company, has opened itsthird plant in the country at a cost of $65 million. The group says that the plant, which will have a production capacity of 50 million units per year, is the most modern in Argentina and one of the few of its kind in Latin America.

Roemmers believes that the plant will help it increase its position in the domestic market, as well as explore the possibilities of strategic alliances with major pharmaceutical multinationals. The company posted 1999 sales in Argentina alone of $298 million and holds a domestic market share of 7.3%. It also has a presence in 16 other Latin American countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight